CG Oncology (CGON)
69.31
-2.41 (3.36%)
Upcoming Events
Latest Headlines
Form 4 CG Oncology, Inc. For: Jul 15 Filed by: POST LEONARD E
July 17, 2026 4:15 PM - SEC Filing
Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw
July 15, 2026 4:25 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jul 10 Filed by: Mulay James
July 14, 2026 4:15 PM - SEC Filing
CG Oncology (CGON) call put ratio 1.4 calls to 1 put as share price down 4.4%
July 13, 2026 2:19 PM - StreetInsider
Form 144 CG Oncology, Inc. Filed by: Mulay James
July 10, 2026 4:41 PM - SEC Filing
Form 144 CG Oncology, Inc. Filed by: Mulay James
July 1, 2026 5:06 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 25 Filed by: Liu Brian Guan-Chyun
June 29, 2026 5:27 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 24 Filed by: POST LEONARD E
June 25, 2026 4:30 PM - SEC Filing
The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
June 25, 2026 11:40 AM - StreetInsider
Form 144 CG Oncology, Inc. Filed by: POST LEONARD E
June 24, 2026 4:38 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 22 Filed by: POST LEONARD E
June 23, 2026 4:30 PM - SEC Filing
Form 144 CG Oncology, Inc. Filed by: POST LEONARD E
June 22, 2026 4:50 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 15 Filed by: Mulay James
June 16, 2026 5:07 PM - SEC Filing
Form 8-K CG Oncology, Inc. For: Jun 04
June 8, 2026 4:02 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 04 Filed by: Liu Brian Guan-Chyun
June 5, 2026 4:31 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 04 Filed by: Tong Victor Edward Jr
June 5, 2026 4:31 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 04 Filed by: Mulay James
June 5, 2026 4:30 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 04 Filed by: POST LEONARD E
June 5, 2026 4:30 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 04 Filed by: Graf Susan E
June 5, 2026 4:30 PM - SEC Filing
Form 4 CG Oncology, Inc. For: Jun 04 Filed by: Rossi Christina
June 5, 2026 4:30 PM - SEC Filing
Form 144 CG Oncology, Inc. Filed by: POST LEONARD E
June 4, 2026 4:29 PM - SEC Filing
CG Oncology to Present at Upcoming Investor Conferences in June
May 28, 2026 4:05 PM - Globe NewsWire
Form 8-K CG Oncology, Inc. For: May 20
May 26, 2026 8:00 AM - SEC Filing
SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 19, 2026 8:00 AM - Globe NewsWire
Wolfe Research Starts CG Oncology (CGON) at Peerperform
May 19, 2026 5:32 AM - StreetInsider
UBS Reiterates Buy Rating on CG Oncology (CGON)
May 18, 2026 10:17 AM - StreetInsider
Form SCHEDULE 13G CG Oncology, Inc. Filed by: T. Rowe Price Investment Management, Inc.
May 15, 2026 10:07 AM - SEC Filing
Form SCHEDULE 13G CG Oncology, Inc. Filed by: RTW INVESTMENTS, LP
May 15, 2026 8:16 AM - SEC Filing
CG Oncology reports positive trial results for bladder cancer therapy
May 15, 2026 8:00 AM - StreetInsider
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026 8:00 AM - Globe NewsWire
CG Oncology (CGON) PT Raised to $82 at Truist Securities
May 14, 2026 6:08 AM - StreetInsider
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
May 11, 2026 4:15 PM - Globe NewsWire
CG Oncology (CGON) PT Raised to $96 at JPMorgan
May 11, 2026 8:01 AM - StreetInsider
CG Oncology (CGON) PT Raised to $81 at RBC Capital
May 11, 2026 7:13 AM - StreetInsider
CG Oncology (CGON) PT Raised to $77 at Truist Securities
May 11, 2026 7:07 AM - StreetInsider
Form 10-Q CG Oncology, Inc. For: Mar 31
May 8, 2026 4:16 PM - SEC Filing
CG Oncology (CGON) PT Maintained at $83 at BofA Securities
May 8, 2026 10:58 AM - StreetInsider
Form 8-K CG Oncology, Inc. For: May 08
May 8, 2026 8:45 AM - SEC Filing
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026 8:30 AM - Globe NewsWire
CG Oncology to Present at Upcoming Investor Conferences in May
May 5, 2026 8:01 AM - Globe NewsWire
UBS Reiterates Buy Rating on CG Oncology (CGON) as AUA 2026 Abstracts Released
April 28, 2026 9:07 AM - StreetInsider
CG Oncology (CGON) PT Raised to $79 at RBC Capital
April 27, 2026 5:39 AM - StreetInsider
Form ARS CG Oncology, Inc. For: Dec 31
April 24, 2026 4:33 PM - SEC Filing
Form DEFA14A CG Oncology, Inc.
April 24, 2026 4:32 PM - SEC Filing
Form DEF 14A CG Oncology, Inc. For: Apr 23
April 24, 2026 4:31 PM - SEC Filing
Full Article List